Does stomach acid really turn CBD into THC? A new review weighs the risk
Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence.
AI Summary
Cannabidiol (CBD) is often formulated to improve its poor oral absorption, but these solubilizing products could theoretically make it more available to stomach acid. That has raised concerns that CBD might convert into tetrahydrocannabinol (THC) during digestion and cause unexpected intoxicating effects. This review revisits the conflicting evidence, focusing especially on a study that found substantial conversion in a specialized simulated gastric fluid containing the surfactant sodium dodecyl sulfate.
The authors argue that conversion requires several conditions at once: low acidity, access of CBD to that acidic environment, and stabilization of a chemical intermediate needed to form THC. They note that other laboratory studies and human data show minimal conversion, and that real stomach conditions differ from simplified laboratory models in acidity, contents, retention time, and movement. Overall, the review concludes that the risk of meaningful CBD-to-THC conversion in humans remains speculative, while recommending more targeted testing of certain micellar formulations in acidic laboratory conditions.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.